세계의 의약품 중간체 시장 - 규모, 점유율, 성장 분석 : 제품별, 카테고리별, 용도별, 최종 사용자별, 지역별, 산업 예측(2024-2031년)
Pharmaceutical Intermediates Market Size, Share, Growth Analysis, By Product, By Category, By Application, By End User, By Region - Industry Forecast 2024-2031
상품코드:1619045
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
의약품 중간체 세계 시장 규모는 2022년에 291억 8,000만 달러로 평가되었고, 2023년 312억 5,000만 달러에서 2031년에는 541억 달러로 성장해 예측기간(2024-2031년) CAGR은 7.1%로 성장할 전망입니다.
의약품 중간체 시장은 이러한 중간체가 의약품 유효성분(API) 생산에 필수적인 원료로서 기능하기 때문에 의약품 및 화장품 섹터에서 수요 증가에 견인되어 대폭적인 성장을 이루고 있습니다. 그리고 맞춤형 의료에 대한 주목이 높아지는 가운데, API에 대한 요구는 높아지고 있으며, 시장 확대에 박차를 가하고 있습니다. 관련 고비용과 원료 생산에 필요한 다액의 설비 투자와 같은 과제는 성장의 방해가 될 수 있습니다. 시장 개척의 기회는 크게 넓어지고 있습니다. 고품질의 기초 원료를 활용하는 것으로, 이 분야는 의약품이나 농약 제조의 다양한 요구에 부응하면서 진화를 계속할 것으로 예상됩니다.
목차
소개
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터의 방법
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인과 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2023년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
규제 분석
특허 분석
사례 연구 분석
의약품 중간체 시장 규모 : 제품별 및 CAGR(2024-2031년)
시장 개요
화학 중간체
벌크 의약품 중간체
키랄 중간체
아키랄 중간체
커스텀 중간체
의약품 중간체 시장 규모 : 카테고리별 및 CAGR(2024-2031년)
시장 개요
브랜드 의약품 중간체
제네릭 의약품 중간체
의약품 중간체 시장 규모 : 용도별 및 CAGR(2024-2031년)
시장 개요
진통제
항염증제
심장혈관약
항당뇨병약
항균제
항암제
기타
의약품 중간체 시장 규모 : 최종 사용자별 및 CAGR(2024-2031년)
시장 개요
바이오테크놀러지 및 제약기업
연구실
CMOS/크로스
의약품 중간체 시장 규모 및 CAGR(2024-2031년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년대비 비교(2021-2023년)
주요 기업 프로파일
BASF SE(Germany)
Sanofi SA(France)
Thermo Fisher Scientific Inc.(US)
Merck KGaA(Germany)
Dishman Carbogen Amcis Ltd.(India)
Evonik Industries AG(Germany)
Arkema Inc.(France)
Lonza Group AG(Switzerland)
Wuxi AppTec Co., Ltd.(China)
Aurobindo Pharma Limited(India)
Lianhe Chemical Technology Co., Ltd.(China)
Cambrex Corporation(US)
Vertellus Holdings LLC(US)
Hovione LLC(Portugal)
Hikal Ltd.(India)
Codexis Inc.(US)
Aceto Corporation(US)
Interchem Corporation(US)
Midas Pharma GmbH(Germany)
Arbiom(US)
결론과 권장사항
JHS
영문 목차
영문목차
Global Pharmaceutical Intermediates Market size was valued at USD 29.18 billion in 2022 and is poised to grow from USD 31.25 billion in 2023 to USD 54.1 billion by 2031, growing at a CAGR of 7.1% during the forecast period (2024-2031).
The pharmaceutical intermediates market is witnessing substantial growth, driven by rising demand in the pharmaceutical and cosmetic sectors as these intermediates serve as essential raw materials in active pharmaceutical ingredient (API) production. With the growing focus on high-tech therapies and personalized medicine, the need for APIs is escalating, further fueling market expansion. However, challenges such as high costs associated with biopharmaceuticals and the significant capital investment required for API production could hinder growth. Nevertheless, advancements in manufacturing technologies and increased investment in research and development are poised to unlock considerable opportunities within the market. By leveraging quality basic materials, the sector is set to continue evolving, catering to the diverse needs of drug and pesticide production.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Intermediates market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Intermediates Market Segmental Analysis
Global Pharmaceutical Intermediates Market is segmented by product, category, application, end user and region. Based on product, the market is segmented into chemical intermediates, bulk drug intermediates, chiral intermediates, achiral intermediates and custom intermediates. Based on category, the market is segmented into branded drug intermediates and generic drug intermediates. Based on application, the market is segmented into analgesics, anti-inflammatory drug, cardiovascular drugs, anti-diabetic drugs, antimicrobial drugs, anti-cancer drugs and others. Based on end user, the market is segmented into biotech and pharma companies, research laboratory and CMOS/CROS. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pharmaceutical Intermediates Market
The Global Pharmaceutical Intermediates market is significantly driven by the rising prevalence of chronic diseases and the aging demographic across the globe. The World Health Organization (WHO) notes that the number of diabetes cases soared from 108 million in 1980 to 422 million by 2014, and this upward trend persists. Moreover, WHO projects that chronic diseases will surge by 57% by 2020, revealing that a considerable proportion of the population is affected. These alarming statistics underscore the escalating demand for drug formulations aimed at managing chronic conditions, thereby fueling substantial growth in the Pharmaceutical Intermediates market during the forecast period.
Restraints in the Global Pharmaceutical Intermediates Market
One significant restraint affecting the global pharmaceutical intermediates market is the substantial expense linked to acquiring biopharmaceutical drugs. This high financial burden not only limits accessibility for many companies but also restricts their ability to invest in research and development. Additionally, the considerable capital investment necessary for the production of active pharmaceutical ingredients (APIs) further hinders market growth. These financial challenges can deter new entrants and stifle innovation within the industry, ultimately impacting the overall development and supply chain of pharmaceutical intermediates and creating barriers to fulfilling market demand.
Market Trends of the Global Pharmaceutical Intermediates Market
The Global Pharmaceutical Intermediates market is experiencing significant growth driven by the escalating prevalence of chronic cardiovascular diseases, particularly ischemic heart disease (IHD), which is projected to impact over 126 million individuals worldwide. As IHD emerges as the leading cause of death globally, with forecasts suggesting an alarming increase to 1,845 cases per 100,000 individuals by 2030, the demand for pharmaceutical intermediates essential for the production of cardiovascular medications is surging. This trend accentuates the urgent need for innovation in drug formulation and production, positioning pharmaceutical intermediates as a critical sector in addressing rising healthcare costs associated with heart disease.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis
Case Study Analysis
Global Pharmaceutical Intermediates Market Size by Product & CAGR (2024-2031)
Market Overview
Chemical Intermediates
Bulk Drug Intermediates
Chiral Intermediates
Achiral Intermediates
Custom Intermediates
Global Pharmaceutical Intermediates Market Size by Category & CAGR (2024-2031)
Market Overview
Branded Drug Intermediates
Generic Drug Intermediates
Global Pharmaceutical Intermediates Market Size by Application & CAGR (2024-2031)
Market Overview
Analgesics
Anti-Inflammatory Drug
Cardiovascular Drugs
Anti-Diabetic Drugs
Antimicrobial Drugs
Anti-Cancer Drugs
Others
Global Pharmaceutical Intermediates Market Size by End User & CAGR (2024-2031)
Market Overview
Biotech and Pharma Companies
Research Laboratory
CMOS/CROS
Global Pharmaceutical Intermediates Market Size & CAGR (2024-2031)
North America (Product, Category, Application, End User)
USA
Canada
Europe (Product, Category, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Category, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Category, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product, Category, Application, End User)
